New Business Models For Personalized Medicine: Look To The Stars?
This article was originally published in The Pink Sheet Daily
Executive Summary‘How to’ on small clinical trials written for NASA may be required reading for drug developers.
You may also be interested in...
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.